Long-term effects of vaginal surgery and endogenous ovarian hormones on the vagina and bladder.

Return to Grants

Publication Year:
2023
Authors:
PubMed ID:
38074491
Public Summary:
Surgery is a common treatment for pelvic organ prolapse; however, risk of recurrence and re-operation is high, resulting in a negative impact on quality of life and sexual function. In this study, we sought to examine the long-term effects of prolapse surgery and ovarian hormones on the vagina and bladder. We tested this in a rat animal model. We found that surgery and deprivation of ovarian hormones resulted in reductions in contractility and elastin/collagen protein in the vagina and bladder. This study allows researchers to gain insights into the long-term effects of surgery and deprivation of ovarian hormones on the vagina and bladder.
Scientific Abstract:
BACKGROUND: Surgery is a common treatment for pelvic organ prolapse (POP); however, risk of recurrence and reoperation is high, resulting in a negative impact on quality of life and sexual function. AIM: To examine the long-term effects of POP surgery and endogenous circulating ovarian hormones on the vagina and bladder. METHODS: Our animal model simulated surgical injury of the vagina and bladder during POP surgery. Female Rowett nude rats were divided into 4 groups: intact control (IC), vaginal surgery only (V), ovariectomy only (O), and ovariectomy + vaginal surgery (OV). Rats were euthanized 10 weeks postsurgery. Proximal vagina and bladder dome/trigone underwent (1) organ bath myography to assess smooth muscle contractility; (2) real-time quantitative polymerase chain reaction to quantify mRNA expression of elastin, collagen I and III, and PGP9.5 (protein gene product 9.5); (3) enzyme-linked immunosorbent assay for protein quantification of elastin and collagen I and III; and (4) hematoxylin-eosin/immunohistochemistry staining. OUTCOMES: The primary outcome was tissue contractility as measured by organ bath myography. Secondary outcomes included gene and protein expression of collagen I and III and elastin. RESULTS: O and OV showed reduced vaginal wall contractility vs IC and V (P < .002). Bladder dome and trigone displayed different contractile patterns, with significant differences between O and OV (P < .05), suggesting a negative effect from surgery rather than ovariectomy. OV demonstrated consistent reductions in contractility and elastin/collagen protein expression for the vagina and bladder vs IC. V had similar contractility and increased collagen I expression vs IC, suggesting a protective effect of ovarian hormones. Vaginal epithelium thinning was confirmed in the ovariectomized groups (P = .001), although there was no statistical significance in muscularis thinning with surgery or ovariectomy. O, V, and OV showed significant downregulation of PGP9.5 mRNA expression vs IC. CLINICAL TRANSLATION: These data allow researchers to gain insights into the long-term effects of surgery and deprivation of ovarian hormones. Future studies can use this animal model to investigate other mechanisms that may affect long-term tissue changes due to surgical intervention. STRENGTHS AND LIMITATIONS: Major strengths are long-term data on the effects of POP surgery and development of an animal model for future studies. However, the animal model limits our ability to extrapolate to humans, where tissue healing is modulated by many factors. CONCLUSION: Our animal model provides evidence that ovarian hormone deprivation and POP surgery result in negative long-term effects on tissue function and extracellular matrix.